Humanised monoclonal antibody therapy for rheumatoid arthritis.

Humanised monoclonal antibody therapy for rheumatoid arthritis.

Monoclonal antibodies that target T cells have shown some benefit in rheumatoid arthritis although responses have not been long lasting. This is partly due to insufficient therapy consequent upon antibody immunogenicity. Use of humanised antibodies, which are expected to be less foreign to man than...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Isaacs, J, Watts, R, Hazleman, B, Hale, G, Keogan, M, Cobbold, S, Waldmann, H
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1992

Παρόμοια τεκμήρια

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
ανά: Isaacs, J, κ.ά.
Έκδοση: (1992)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
ανά: Isaacs, J, κ.ά.
Έκδοση: (2004)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
ανά: Isaacs, J, κ.ά.
Έκδοση: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
ανά: Isaacs, J, κ.ά.
Έκδοση: (2005)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
ανά: Kyle, V, κ.ά.
Έκδοση: (1991)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
ανά: Isaacs, J, κ.ά.
Έκδοση: (2002)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
ανά: Watts, R, κ.ά.
Έκδοση: (1992)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
ανά: Isaacs, J, κ.ά.
Έκδοση: (1998)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
ανά: Isaacs, J, κ.ά.
Έκδοση: (1996)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
ανά: Kyle, V, κ.ά.
Έκδοση: (1989)

Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
ανά: Lawson, C, κ.ά.
Έκδοση: (2005)

Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.
ανά: Morgan, A, κ.ά.
Έκδοση: (1997)

CAMPATH-1H in inflammatory arthritis.
ανά: Watts, R, κ.ά.
Έκδοση: (1993)

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
ανά: Isaacs, J, κ.ά.
Έκδοση: (1997)

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
ανά: Isaacs, J, κ.ά.
Έκδοση: (2001)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
ανά: Isaacs, J, κ.ά.
Έκδοση: (1996)

Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
ανά: Lorenzi, A, κ.ά.
Έκδοση: (2008)

Advantages of rat monoclonal antibodies.
ανά: Clark, M, κ.ά.
Έκδοση: (1983)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
ανά: Waldmann, H, κ.ά.
Έκδοση: (2001)

Monoclonal-antibody therapy in systemic vasculitis.
ανά: Mathieson, P, κ.ά.
Έκδοση: (1990)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
ανά: Lockwood, C, κ.ά.
Έκδοση: (1993)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
ανά: Lockwood, C, κ.ά.
Έκδοση: (1993)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
ανά: Lockwood, C, κ.ά.
Έκδοση: (1995)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
ανά: Waldmann, H, κ.ά.
Έκδοση: (1982)

MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
ανά: Isaacs, J, κ.ά.
Έκδοση: (1993)

Monoclonal antibodies for the induction of transplantation tolerance.
ανά: Waldmann, H, κ.ά.
Έκδοση: (1993)

Therapeutic potential of monovalent monoclonal antibodies.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1984)

The use of monoclonal antibodies to achieve immunological tolerance.
ανά: Waldmann, H, κ.ά.
Έκδοση: (1993)

Corrigendum: Therapeutic potential of monovalent monoclonal antibodies
ανά: Cobbold, S, κ.ά.
Έκδοση: (1984)

The use of monoclonal antibodies to achieve immunological tolerance.
ανά: Waldmann, H, κ.ά.
Έκδοση: (1993)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
ανά: Hale, G, κ.ά.
Έκδοση: (1989)

Monoclonal antibodies for the therapeutic induction of tolerance.
ανά: Waldmann, H, κ.ά.
Έκδοση: (1993)

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1984)

Monoclonal antibodies for immunosuppression.
ανά: Waldmann, H, κ.ά.
Έκδοση: (1988)

Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.
ανά: Waldmann, H, κ.ά.
Έκδοση: (1992)

Reprogramming the immune system for tolerance with monoclonal antibodies.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1990)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1990)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
ανά: Cobbold, S, κ.ά.
Έκδοση: (1990)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
ανά: Isaacs, J, κ.ά.
Έκδοση: (1992)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
ανά: Isaacs, J, κ.ά.
Έκδοση: (1995)